Navigating the Regulatory Pathways and Requirements for Tissue-Engineered Products in the Treatment of Burns in the United States.

Publication Year: 2021

DOI:
10.1093/jbcr/iraa210

PMCID:
PMC8335953

PMID:
33301575

Journal Information

Full Title: J Burn Care Res

Abbreviation: J Burn Care Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Traumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest statement: Kimberly Belsky and Janice Smiell are employees and shareholders of Mallinckrodt Pharmaceuticals."

Evidence found in paper:

"Funding: This work was funded by Mallinckrodt Pharmaceuticals, plc., Hampton, NJ.: Conflict of interest statement: Kimberly Belsky and Janice Smiell are employees and shareholders of Mallinckrodt Pharmaceuticals."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025